NFSG
CRBU icon

Newbridge Financial Services Group’s Caribou Biosciences CRBU Stock Holding History

Newbridge Financial Services Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.8K Hold
2,000
– – ﹤0.01% 954
2025
Q4 		$3.18K Hold
2,000
– – ﹤0.01% 972
2025
Q3 		$4.66K Hold
2,000
– – ﹤0.01% 1033
2025
Q2 		$2.52K Hold
2,000
– – ﹤0.01% 1118
2025
Q1 		$1.83K Hold
2,000
– – ﹤0.01% 900
2024
Q4 		$3.18K Buy
+2,000
New +$4.02K ﹤0.01% 916
2024
Q3 		– Sell
-2,000
Closed -$3.28K – 739
2024
Q2 		$3.28K Hold
2,000
– – ﹤0.01% 902
2024
Q1 		$10.3K Hold
2,000
– – ﹤0.01% 763
2023
Q4 		$11.5K Hold
2,000
– – 0.01% 707
2023
Q3 		$9.56K Buy
+2,000
New +$12.4K ﹤0.01% 829

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return